-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $70

Benzinga·05/14/2025 15:42:32
Listen to the news
Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $75 to $70.